重庆医学
重慶醫學
중경의학
CHONGQING MEDICAL JOURNAL
2015年
2期
207-208,211
,共3页
静脉血栓形成%下肢%栓塞 ,治疗性%瑞替普酶%重组链激酶
靜脈血栓形成%下肢%栓塞 ,治療性%瑞替普酶%重組鏈激酶
정맥혈전형성%하지%전새 ,치료성%서체보매%중조련격매
venous thrombosis%lower extremity%embolization,therapeutic%reteplase%recombinant streptokinase
目的:探讨下肢深静脉血栓(DVT)的有效治疗方法。方法对该院60例下肢DVT患者进行回顾性分析,32例予瑞替普酶溶栓治疗(瑞替普酶溶栓组),与随机选取同期予重组链激酶溶栓治疗28例(重组链激酶溶栓组)作对比。治疗期间观察患肢变化和有无不良反应,对疗效进行评价。结果两组患者临床全部达到有效,愈显率相比瑞替普酶溶栓组高于重组链激溶栓组,差异有统计学意义(P<0.05)。不良反应比较,瑞替普酶溶栓组低于重组链激溶栓组,但两组差异无统计学意义(P>0.05)。随访期间两组均未见复发病例。结论瑞替普酶治疗下肢深静脉血栓形成是有效的、安全的。
目的:探討下肢深靜脈血栓(DVT)的有效治療方法。方法對該院60例下肢DVT患者進行迴顧性分析,32例予瑞替普酶溶栓治療(瑞替普酶溶栓組),與隨機選取同期予重組鏈激酶溶栓治療28例(重組鏈激酶溶栓組)作對比。治療期間觀察患肢變化和有無不良反應,對療效進行評價。結果兩組患者臨床全部達到有效,愈顯率相比瑞替普酶溶栓組高于重組鏈激溶栓組,差異有統計學意義(P<0.05)。不良反應比較,瑞替普酶溶栓組低于重組鏈激溶栓組,但兩組差異無統計學意義(P>0.05)。隨訪期間兩組均未見複髮病例。結論瑞替普酶治療下肢深靜脈血栓形成是有效的、安全的。
목적:탐토하지심정맥혈전(DVT)적유효치료방법。방법대해원60례하지DVT환자진행회고성분석,32례여서체보매용전치료(서체보매용전조),여수궤선취동기여중조련격매용전치료28례(중조련격매용전조)작대비。치료기간관찰환지변화화유무불량반응,대료효진행평개。결과량조환자림상전부체도유효,유현솔상비서체보매용전조고우중조련격용전조,차이유통계학의의(P<0.05)。불량반응비교,서체보매용전조저우중조련격용전조,단량조차이무통계학의의(P>0.05)。수방기간량조균미견복발병례。결론서체보매치료하지심정맥혈전형성시유효적、안전적。
Objective To investigate the treatment of the lower extremity deep venous thrombosis .Methods Sixty patients with lower extremity deep venous thrombosis were analyzed retrospectively .Thirty two patients underwent reteplase thrombosis ,and 28 patients underwent recombinant streptokinase thrombosis ;the effects of each group were compared;and the various complications and adverse events were observed .Results Patients in two groups were all effectively treated ,and the effective rate of reteplase group was higher than recombinant streptokinase group (P<0 .05) .The adverse rate of reteplase group was lower than recombi‐nant streptokinase group ,but there was no significant difference between two groups (P>0 .05) .During the follow‐up ,there was no reoccurrence in all 60 patients .Conclusion Reteplase thrombolytic therapy for the lower extremity deep venous thrombosis is safe and effective .